SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001808805-23-000045
Filing Date
2023-05-02
Accepted
2023-05-01 17:44:25
Documents
13
Period of Report
2023-05-02
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K naut-20230502.htm   iXBRL 8-K 36652
2 EX-99.1 exhibit991-2023q18xk.htm EX-99.1 87239
  Complete submission text file 0001808805-23-000045.txt   273910

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT naut-20230502.xsd EX-101.SCH 1902
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT naut-20230502_lab.xml EX-101.LAB 24835
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT naut-20230502_pre.xml EX-101.PRE 13045
7 EXTRACTED XBRL INSTANCE DOCUMENT naut-20230502_htm.xml XML 11991
Mailing Address 2701 EASTLAKE AVE EAST SEATTLE WA 98102
Business Address 2701 EASTLAKE AVE EAST SEATTLE WA 98102 206-333-2001
Nautilus Biotechnology, Inc. (Filer) CIK: 0001808805 (see all company filings)

IRS No.: 981541723 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39434 | Film No.: 23875510
SIC: 3826 Laboratory Analytical Instruments